Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SOBP | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | IL4I1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | SLC16A10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | GOLGB1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | CSDC2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | POLR2D | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | MTUS2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | DYNLL2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TLDC1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | GLG1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |